Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients

Journal of Neurology

Volumn 258, Issue 3, 2011, Pages 464-470

  Akman Demir, Gulsen ^a   Tüzün, Erdem ^a   Waters, Patrick ^b   Içöz, Sema ^a   Kürtüncü, Murat ^c   Jarius, Sven ^b   Yapici, Zuhal ^a   Mutlu, Melike ^a   Yeşilot, Nilüfer ^a   Vincent, Angela ^b   Eraksoy, Mefkure ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ACIBADEM UNIVERSITY   (Turkey)

Author keywords

Anti aquaporin 4 antibodies; Aquaporin 4 seropositivity; Multiple sclerosis; Neuromyelitis optica; NMO IgG; Prognosis

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PROTEIN ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISABILITY SEVERITY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYELOOPTIC NEUROPATHY; ONSET AGE; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SCHOOL CHILD; SERODIAGNOSIS; STEROID THERAPY; TURKEY (REPUBLIC); UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PROGNOSIS; TURKEY; YOUNG ADULT;

EID: 79953781568     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5780-4     Document Type: Article

References (18)

1. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P (2002) Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 197:57-61 (Pubitemid 34462145)
2. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114 (Pubitemid 29442132)
3. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390-396
4. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H (2002) A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125:1450-1461 (Pubitemid 34755161)
5. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112 (Pubitemid 39626806)
6. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005) IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477 (Pubitemid 41186945)
7. Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131:3072-3080
8. Akman-Demir G, Eraksoy M, Tüzün E, Jarius S, Icoz S, Kurtuncu M, Waters P, Yapici Z, Mutlu M, Vincent A (2008) Devic's neuromyelitis optica: an analysis of 47 patients and prognostic implications of NMO IgG status. Neurology 70(Suppl.1):A-267 abstract
9. Wingerchuck DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485-1489 (Pubitemid 43958540)
10. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65:913-919 (Pubitemid 352008474)
11. Cabrera-Gómez JA, Bonnan M, González-Quevedo A, Saiz- Hinarejos A, Marignier R, Olindo S, Graus F, Smadja D, Merle H, Thomas L, Gómez-García A, Cabre P (2009) Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler 15:828-833
12. Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC (2010) Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349-361
13. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA (2006) Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 59:566-569 (Pubitemid 43358081)
14. Kanzaki M, Mochizuki H, Ogawa G, Tanaka K, Araki M, Motoyoshi K, Hammond-Tooke G, Kamakura K (2008) Clinical features of opticospinal multiple sclerosis with anti-aquaporin-4 antibody. Eur Neurol 60:37-42 (Pubitemid 351799066)
15. Içöz S, Tüzün E, Kürtüncü M, Durmuş H, Mutlu M, Eraksoy M, Akman-Demir G (2010) Enhanced IL-6 production in aquaporin- 4 antibody positive neuromyelitis optica patients. Int J Neurosci 120:71-75
16. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A (2007) NMO IgG in the diagnosis of neuromyelitis optica. Neurology 68:1076-1077 (Pubitemid 46569147)
17. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, Watanabe S, Takahashi T, Nishiyama S, Shiga Y, Sato S, Weinshenker BG, Itoyama Y (2006) Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 77:1073-1075 (Pubitemid 44338534)
18. Klawiter EC, Alvarez E 3rd, Xu J, Paciorkowski AR, Zhu L, Parks BJ, Cross AH, Naismith RT (2009) NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 72:1101-1103